INIS
patients
100%
cancer
53%
diseases
25%
indonesia
20%
levels
20%
hospitals
19%
pain
19%
metastases
17%
therapy
17%
carcinomas
16%
management
14%
breasts
12%
lymphomas
12%
asia
12%
bones
11%
values
11%
data
10%
inflammation
10%
chemotherapy
9%
covid-19
9%
biological markers
9%
coronaviruses
9%
stem cells
9%
mortality
8%
quality of life
8%
bone marrow
8%
populations
8%
correlations
8%
plasma
7%
receptors
7%
proteins
7%
genes
7%
symptoms
6%
blood
6%
infusion
6%
neutrophils
6%
tumors
6%
analgesics
6%
control
6%
screening
6%
lymphocytes
6%
myocardial infarction
6%
assessments
5%
evaluation
5%
Keyphrases
Indonesia
21%
Cancer Patients
16%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
15%
COVID-19
12%
Pada
11%
Pain Management
10%
Palliative Patients
9%
Cyclin D1 (CCND1)
9%
Bone Marrow Mononuclear Cells
9%
Asian Patients
9%
Breast Cancer Patients
7%
Bone Metastasis
7%
General Hospital
7%
Opioids
7%
Progression-free Survival
6%
Locally Advanced
6%
Cancer Pain
6%
South-East Asia
6%
Indonesian
6%
Indonesian Population
6%
Quality of Life
6%
Chemotherapy
6%
Advanced Breast Cancer
6%
Asia
6%
Jakarta
6%
Peripheral Blood Stem Cells
6%
Analgesic Treatment
6%
Tertiary Hospital
6%
Neutrophil-lymphocyte Ratio
6%
Advanced Nasopharyngeal Carcinoma
6%
Prospective Registry
6%
Registry Study
6%
Dari
5%
No Significant Difference
5%
Medicine and Dentistry
Nasopharynx Cancer
15%
Malignant Neoplasm
14%
Nasopharynx Carcinoma
12%
Quality of Life
11%
Diagnosis
9%
Diseases
9%
Cyclin D1
9%
Progression Free Survival
8%
Neoplasm
7%
Analgesia
7%
Mononuclear Cell
7%
Symptomatic Treatment
6%
Cancer Pain
6%
Lymphocyte
6%
Neutrophil
6%
Cross Sectional Study
5%
Cancer Pain Management
5%
Sleep Disorder
5%
